Related Experiment Videos
Renal failure after treatment with interferon alpha 2b
W W H Roeloffzen1, G A P Hospers, E G E De Vries
1University Hospital Groningen, Department of Internal Medicine, The Netherlands.
Anticancer Research
|August 10, 2002
Summary
Interferon alpha 2b treatment, used for cancers, can rarely cause kidney failure. This case highlights a patient who developed acute on chronic renal failure 16 months after starting interferon therapy.
Area of Science:
- Nephrology
- Oncology
- Pharmacology
Background:
- Interferons are widely used in treating malignancies and viral infections.
- Acute kidney injury is a rarely reported side effect of interferon therapy.
- Interferon alpha 2b is a common therapeutic agent in oncology.
Observation:
- A patient with metastatic carcinoid tumor was treated with interferon alpha 2b.
- The patient developed acute on chronic renal failure.
- Renal failure occurred 16 months after the initiation of interferon therapy.
Findings:
- This case demonstrates a rare instance of renal impairment secondary to interferon alpha 2b.
- The patient's pre-existing chronic kidney disease was exacerbated, leading to acute on chronic renal failure.
- The temporal association suggests a potential link between interferon alpha 2b and the observed renal deterioration.
Implications:
- Clinicians should be vigilant for renal side effects in patients receiving interferon therapy, especially those with pre-existing kidney conditions.
- Further investigation into the mechanisms of interferon-induced nephrotoxicity may be warranted.
- This case underscores the importance of monitoring renal function during long-term interferon treatment for metastatic cancers.